Factorial Partners’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,300
Closed -$338K 99
2022
Q2
$338K Sell
10,300
-15,200
-60% -$480K 0.27% 82
2022
Q1
$670K Sell
25,500
-14,600
-36% -$356K 0.46% 69
2021
Q4
$952K Buy
40,100
+1,300
+3% +$32.1K 0.63% 59
2021
Q3
$973K Buy
38,800
+12,000
+45% +$306K 0.66% 57
2021
Q2
$696K Sell
26,800
-10,400
-28% -$283K 0.47% 69
2021
Q1
$953K Buy
37,200
+800
+2% +$20.5K 0.67% 52
2020
Q4
$729K Buy
36,400
+4,100
+13% +$80.3K 0.61% 59
2020
Q3
$553K Buy
32,300
+23,500
+267% +$444K 0.57% 64
2020
Q2
$192K Sell
8,800
-2,400
-21% -$54.9K 0.21% 84
2020
Q1
$259K Sell
11,200
-400
-3% -$11.6K 0.35% 73
2019
Q4
$369K Hold
11,600
0.17% 102
2019
Q3
$369K Sell
11,600
-16,000
-58% -$466K 0.35% 84
2019
Q2
$709K Sell
27,600
-1,500
-5% -$38.2K 0.68% 49
2019
Q1
$739K Buy
29,100
+20,400
+234% +$609K 0.7% 53
2018
Q4
$296K Buy
8,700
+5,600
+181% +$182K 0.31% 95
2018
Q3
$111K Buy
+3,100
New +$109K 0.09% 97
2018
Q2
Sell
-11,300
Closed -$380K 115
2018
Q1
$380K Buy
+11,300
New +$358K 0.35% 82

Other funds holding NTUS

Factorial Partners's NTUS Position: Q3 2022 in Review

Factorial Partners sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 10,300 shares — an estimated $338K sold.

Factorial Partners first reported a position in NTUS in Q1 2018 and held it in 17 quarters. The position peaked at $973K in Q3 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Factorial Partners reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Factorial Partners sold 10,300 Natus Medical Inc shares in Q3 2022, an estimated $338K.
  • Factorial Partners first reported a position in Natus Medical Inc in Q1 2018 and held it in 17 quarters.
  • Factorial Partners's Natus Medical Inc position peaked at $973K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Factorial Partners's 13F filing for Q3 2022, filed 4 Nov 2022.